Knight Jeff E.
Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX) · Chief Operating Officer
Knight Jeff E. is listed in filings as Chief Operating Officer at Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX). This profile follows SEC Form 4 activity through Apr 17, 2026, including sale activity. Recent filings connect the profile to Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX) (CRNX) and ALX Oncology Holdings Inc. (ALXO). The current snapshot covers public activity from Jun 28, 2024 to Apr 17, 2026. Reported amounts are shown as $42.4K to $57.8K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Current Price |
|---|---|---|---|---|
| $42k956 shares | SellJun 26, 2024 | $44.38 | $83.65 | |
| $1M27k shares | SellJul 15, 2024 | $55.00 | $83.65 | |
| $28k501 shares | SellNov 22, 2024 | $56.52 | $83.65 | |
| $13k361 shares | SellMar 19, 2025 | $34.83 | $83.65 | |
| $232k6.8k shares | SellMar 19, 2025 | $34.17 | $83.65 | |
| $150k4k shares | SellMar 16, 2026 | $37.77 | $83.65 | |
| $221k6k shares | SellMar 16, 2026 | $37.11 | $83.65 |